crane(CR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CR crane

已收盘 02-04 16:00:00 EST

189.82

-0.58

-0.30%

盘后189.05

-0.77-0.41%

18:24 EST

最高192.96	最低186.83	成交量63.50万
今开190.54	昨收190.40	日振幅3.22%
总市值109.33亿	流通市值92.57亿	总股本5,760万
成交额1.21亿	换手率1.30%	流通股本4,876万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CR","market":"US","secType":"STK","nameCN":"crane","latestPrice":189.82,"timestamp":1770238800000,"preClose":190.4,"halted":0,"volume":635022,"hourTrading":{"tag":"盘后","latestPrice":189.05,"preClose":189.82,"latestTime":"18:24 EST","volume":3324,"amount":630851.45,"timestamp":1770247456740,"change":-0.77,"changeRate":-0.004056,"amplitude":0.004056},"delay":0,"changeRate":-0.0030462184873950235,"floatShares":48764858,"shares":57596887,"eps":6.247815,"marketStatus":"已收盘","change":-0.58,"latestTime":"02-04 16:00:00 EST","open":190.54,"high":192.96,"low":186.83,"amount":120538301.18544,"amplitude":0.032195,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.247815,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770282000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":190.4,"dividendRate":0.004847,"preHourTrading":{"tag":"盘前","latestPrice":191,"preClose":190.4,"latestTime":"09:24 EST","volume":145,"amount":27693.985,"timestamp":1770215081794,"change":0.6,"changeRate":0.003151,"amplitude":0.0052},"postHourTrading":{"tag":"盘后","latestPrice":189.05,"preClose":189.82,"latestTime":"18:24 EST","volume":3324,"amount":630851.45,"timestamp":1770247456740,"change":-0.77,"changeRate":-0.004056,"amplitude":0.004056},"volumeRatio":0.823393,"impliedVol":0.2908,"impliedVolPercentile":0.2869},"requestUrl":"/m/hq/s/CR","defaultTab":"news","newsList":[{"id":"1174403910","title":"克瑞公司公布2025年第四季度强劲业绩，启动2026年财年指引，完成两项收购并宣布领导层过渡计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1174403910","media":"美股速递","labels":["executive","corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174403910?lang=zh_cn&edition=full","pubTime":"2026-01-27 05:17","pubTimestamp":1769462235,"startTime":"0","endTime":"0","summary":"克瑞公司近日披露了其2025财年第四季度的卓越财务表现，多项关键指标均展现出强劲的增长势头。与此同时，公司正式启动了针对2026财年的业绩展望，为未来的发展路径设定了清晰的预期。\n在业务拓展方面，克瑞公司成功完成了两项战略性收购，此举预计将进一步提升其市场竞争力并拓宽业务范围。此外，公司还公布了一项关于领导层交接的详细过渡计划，旨在确保管理团队的平稳迭代和公司战略的延续性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","CR"],"gpt_icon":0},{"id":"1117870991","title":"财报前瞻｜crane本季度营收预计增7.13%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1117870991","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117870991?lang=zh_cn&edition=full","pubTime":"2026-01-19 10:09","pubTimestamp":1768788588,"startTime":"0","endTime":"0","summary":"crane将于2026年01月26日发布最新季度财报，市场聚焦收入与利润修复的延续性以及两大业务平台的增长质量。crane上季度实现营收5.89亿美元，同比降1.34%；毛利率42.65%，同比变动未披露；归属母公司净利润9,140.00万，同比与环比数据以环比增5.79%为准；净利率15.51%；调整后每股收益1.64美元，同比增18.84%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜crane本季度营收预计增7.13%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR"],"gpt_icon":0},{"id":"2601720568","title":"华营建筑(01582)：针对CR Sea的清盘令已终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2601720568","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601720568?lang=zh_cn&edition=full","pubTime":"2026-01-07 19:24","pubTimestamp":1767785054,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华营建筑(01582)发布公告，就有关法院于2025年10月14日对CR Sea(本公司间接全资附属公司)颁发清盘令的相关事宜。法院于2026年1月7日颁布终止清盘令的命令。因此，于本公告日期，并无针对CR Sea的尚未裁决的清盘呈请或清盘令。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01582","CR","BK4161","BK1148"],"gpt_icon":0},{"id":"1185718973","title":"克瑞公司完成对精密传感器与仪器业务的收购，并公布2025年第四季度财报发布日期及电话会议安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1185718973","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185718973?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:31","pubTimestamp":1767616300,"startTime":"0","endTime":"0","summary":"克瑞公司（Crane Company）已正式完成对Precision Sensors & Instrumentation业务的收购，此举标志着公司在拓展高精度测量技术领域迈出关键一步。与此同时，公司管理层还确定了2025年第四季度财务业绩的发布日期，并计划举行投资者电话会议，届时将详细解读财报数据及战略规划。\n此次收购将强化克瑞在工业自动化解决方案领域的技术储备，而财报会议的安排则体现了公司对投资者沟通透明度的重视。市场预期，新财季数据将反映收购案对业务结构的初步影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","CR"],"gpt_icon":0},{"id":"2593176440","title":"多个新药或新适应症获FDA批准，涉及肿瘤、肥胖、肺纤维化等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2593176440","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593176440?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:16","pubTimestamp":1766538973,"startTime":"0","endTime":"0","summary":"近日，多个创新药或新适应症获美国食品药品监督管理局批准，涉及罗氏、诺和诺德、勃林格殷格翰等。这些新药覆盖肿瘤、肥胖、肺纤维化等多个治疗领域，为患者带来了新的治疗选择。此次FDA批准基于关键性3期FIBRONEER-ILD临床试验结果，数据显示Jascayd可有效减缓PPF患者的肺功能下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224091748a6c7f4a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224091748a6c7f4a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4161","NVO","CR","ORR"],"gpt_icon":0},{"id":"2592979902","title":"华营建筑(01582)：CR Sea将竭尽全力于2026年1月7日举行的聆讯中争取终止的裁决","url":"https://stock-news.laohu8.com/highlight/detail?id=2592979902","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592979902?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:17","pubTimestamp":1766049453,"startTime":"0","endTime":"0","summary":"CR Sea与分包商已于2025年11月7日签订最终和解协议，据此CR Sea须向分包商支付55.16万令吉，该款项已由CR Sea于同日全数结清。CR Sea将竭尽全力于2026年1月7日举行的聆讯中争取终止的裁决。相反地，CR Sea董事会于2025年7月28日与分包商达成和解协议，并分别于2025年9月22日及2025年10月1日支付第一期及第二期款项。尽管已收到前两期款项的付款，但分包商并未向法院申请撤回呈请，法院遂于2025年10月14日在CR Sea法律代表缺席的情况下对其颁发清盘令。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1148","BK4161","01582","CR"],"gpt_icon":0},{"id":"2590451393","title":"吉利德Anito-cel 神经毒性低，2年多发性骨髓瘤生存率高 | ASH25","url":"https://stock-news.laohu8.com/highlight/detail?id=2590451393","media":"Minhua笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590451393?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:58","pubTimestamp":1765166299,"startTime":"0","endTime":"0","summary":"在ASH 2025年会上，吉利德旗下Kite Pharma公布Anito-cel在iMMagine-1 II期试验中的更新数据，该靶向BCMA的CAR-T疗法在复发/难治性多发性骨髓瘤患者中显示96% ORR、74% sCR/CR率、95% MRD阴性率，中位随访15.9个月，缓解持续。III期iMMagine-3试验正在招募中，该研究将Anito-cel与标准治疗比较，预计2026年获得数据；该药物获FDA快速通道、孤儿药和RMAT资格。ICANS 发生率为 8%，其中 1 例为 3 级；其余均为 2 级或更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B66KJ199.SGD","OS","IE00B19Z3581.USD","LU0889565916.HKD","LU1430594728.SGD","SG9999015945.SGD","IE0002270589.USD","ORR","IE00B7SZLL34.SGD","ASH","SG9999015952.SGD","BK4568","LU0882574055.USD","BK4195","LU0320765992.SGD","LU1571399168.USD","BK4578","GILD","LU1674673428.USD","CRS","BK4109","LU0823416689.USD","IE00B19Z3B42.SGD","BK4139","SG9999015986.USD","PFS","BK4566","BK4097","BK4187","LU0234570918.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU1066051498.USD","BK4585","LU0289739699.SGD","IE00B3T34201.USD","IE00B7SZL793.SGD","CR","LU1839511570.USD","KOL","BK4588","LU1585245621.USD","IE00B19Z4B17.USD","LU1778281490.HKD","SG9999015978.USD","BK4550","IE00BKVL7J92.USD","BK4532"],"gpt_icon":0},{"id":"2584846461","title":"三峡库区再度发现荷叶铁线蕨野生种群","url":"https://stock-news.laohu8.com/highlight/detail?id=2584846461","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584846461?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:06","pubTimestamp":1763629560,"startTime":"0","endTime":"0","summary":"2023年4月，科研人员在重庆市万州区首次发现零星分布的荷叶铁线蕨野生种群。此次调查，科研人员历时多日对三峡库区典型区域进行系统踏查，最终在重庆万州区新乡镇、武陵镇、燕山乡等地发现3个荷叶铁线蕨野生种群，共计100余株，均分布于人迹罕至的崖壁与峡谷阴湿处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-11-20/doc-infxzvma0908319.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-20/doc-infxzvma0908319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4161","CR"],"gpt_icon":0},{"id":"2583631777","title":"Crane Hbr Acquisition Corp Unit 1 Cl A & 1 Rt盘中异动 急速跳水6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583631777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583631777?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:45","pubTimestamp":1763135102,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日23时45分，Crane Hbr Acquisition Corp Unit 1 Cl A & 1 Rt股票出现波动，股价大幅跳水6.02%。Crane Hbr Acquisition Corp Unit 1 Cl A & 1 Rt股票所在的壳公司行业中，整体涨幅为0.00%。Crane Hbr Acquisition Corp Unit 1 Cl A & 1 Rt公司简介：Crane Harbor Acquisition Corp 是一家空白支票公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114234502a4a1f8db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114234502a4a1f8db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4161","CR","CHACU"],"gpt_icon":0},{"id":"2580442918","title":"美国，突发！超1000架次航班取消！","url":"https://stock-news.laohu8.com/highlight/detail?id=2580442918","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580442918?lang=zh_cn&edition=full","pubTime":"2025-11-01 13:14","pubTimestamp":1761974040,"startTime":"0","endTime":"0","summary":"　　美国政府“停摆”的影响正在加剧。　　受“停摆”影响，美国多地机场航班延误甚至取消。据美国航班跟踪网站的数据，仅美东时间10月30日当天，全美因各种原因已有超过6000架次航班延误，超1000架次航班取消。美国副总统万斯当天警告称，如果“停摆”持续到11月下旬的感恩节假期旅行季，美国航空交通可能将面临一场“灾难”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/world/gjcj/2025-11-01/doc-infvwmtz3633954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4576","BK4554","GDP","BK4077","BK4161","BK4551","BK4508","BK4213","CR"],"gpt_icon":0},{"id":"1151777346","title":"Crane Company公布2025年第三季度财报；上调并缩小全年的调整后每股收益指导区间","url":"https://stock-news.laohu8.com/highlight/detail?id=1151777346","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151777346?lang=zh_cn&edition=full","pubTime":"2025-10-28 04:16","pubTimestamp":1761596176,"startTime":"0","endTime":"0","summary":"Crane Company公布2025年第三季度财报；上调并缩小全年的调整后每股收益指导区间","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","BK4161"],"gpt_icon":0},{"id":"2577317898","title":"寻买家失败，biotech放弃细胞治疗业务断臂求生","url":"https://stock-news.laohu8.com/highlight/detail?id=2577317898","media":"细胞基因治疗前沿","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577317898?lang=zh_cn&edition=full","pubTime":"2025-10-22 11:08","pubTimestamp":1761102492,"startTime":"0","endTime":"0","summary":"继武田制药和诺和诺德先后宣布退出细胞治疗领域后，又一家biotech宣布关闭细胞业务，细胞治疗赛道正经历新一轮残酷洗牌，行业进入理性收缩与调整阶段。10月21日，Galapgos宣布在对战略替代方案进行全面审查，包括潜在的资产剥离后，最终决定逐步关闭其细胞治疗业务，并利用现有现金资源寻求新的转型业务发展交易。除吉利德任命的两名董事外，Galapagos董事会一致批准了逐步关闭细胞治疗业务的意向，这两名董事均回避了投票。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022114843a46d923b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022114843a46d923b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CR","BK4077","BK4161","GLPG","BK4546","DM","SLE"],"gpt_icon":0},{"id":"2575793285","title":"巨轮智能：RV减速器通过CR产品认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2575793285","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575793285?lang=zh_cn&edition=full","pubTime":"2025-10-16 12:05","pubTimestamp":1760587504,"startTime":"0","endTime":"0","summary":"证券之星消息，巨轮智能(002031)10月15日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好：贵司研发的xT减速机，己通过欧盟CE、北美UL认证。为何没见公告？谢啦巨轮智能回复：您好！目前公司减速器产品已获得国家机器人检测与评定中心颁发的RV减速器CR产品认证证书，公司是国内首批获得该认证的两家企业之一，填补了中国机器人CR认证在该领域的空白。详见公司《关于RV减速器通过CR产品认证的公告(公告编号2023-015)》，谢谢关注！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251016/31711344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0061","BK0251","CR","BK0130","BK0028","BK4161","BK0039","002031"],"gpt_icon":0},{"id":"2574538681","title":"药明巨诺：国产病毒载体版倍诺达补充申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2574538681","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574538681?lang=zh_cn&edition=full","pubTime":"2025-10-09 17:48","pubTimestamp":1760003334,"startTime":"0","endTime":"0","summary":"10月9日，药明巨诺（02126）发布公告，中国国家药品监督管理局已正式受理公司倍诺达?使用国产病毒载体的上市后补充申请。此次申请基于一项II期单臂研究，旨在评估使用新工艺病毒载体（JWLV011）生产的瑞基奥仑赛注射液与现有病毒载体生产的产品可比性。研究结果显示，3个月最佳客观缓解率（ORR）为66.67%，疾病完全缓解率（CR）为41.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510093529591131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ORR","BK4161","CR"],"gpt_icon":0},{"id":"2570883771","title":"金融市场或再遭重锤! 白宫着手制定“政府关门预案” 大裁员迫在眉睫","url":"https://stock-news.laohu8.com/highlight/detail?id=2570883771","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570883771?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:19","pubTimestamp":1758889194,"startTime":"0","endTime":"0","summary":"“在2026财年拨款生效后，各联邦政府机构应根据需要调整其RIF，以保留履行法定政府职能所需的最低员工数量，”这份备忘录补充表示。在过去数十年间，联邦政府关门期间的联邦工作人员通常会被无薪休假，直至达成预算协议，之后再返回工作岗位。因此，特朗普政府拟推行的大规模RIF的可行性与合法性在关门场景下正受到质疑，且面临政治与司法层面的挑战。联邦资金定于9月30日到期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4161","CR"],"gpt_icon":0},{"id":"2569718850","title":"直降4万元！CR-V全球30年荣耀款上市，售价14.59万元起","url":"https://stock-news.laohu8.com/highlight/detail?id=2569718850","media":"Ofweek光电信息网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569718850?lang=zh_cn&edition=full","pubTime":"2025-09-23 15:29","pubTimestamp":1758612540,"startTime":"0","endTime":"0","summary":"在9月22日CR-V全球30年荣耀款上市发布会上，东风本田汽车有限公司执行副总经理曹东杰如此总结能够持续热销的原因。另外，在今年9月15日，本田CR-V全球累计销量突破1500万辆。9月22日，东风本田CR-V全球30年荣耀款正式上市，推出燃油、混动两个动力版本共11款车型，全系指导价为18.59万-24.99万元。在这一指导价基础上，东风本田宣布新款CR-V售价限时直降4万元，售价直接来到了14.59万-20.99万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923153515953f936a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923153515953f936a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HMC","BK4555","00489","BK4585","CR","BK4161","BK4099","BK4588"],"gpt_icon":0},{"id":"2569789095","title":"智元斩获业内首张人形机器人数据集CR认证，编号“001”","url":"https://stock-news.laohu8.com/highlight/detail?id=2569789095","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569789095?lang=zh_cn&edition=full","pubTime":"2025-09-22 19:30","pubTimestamp":1758540623,"startTime":"0","endTime":"0","summary":"更多消息，持续更新中","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/d0/24/94/-1-2-.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/d0/24/94/-1-2-.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3756044","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3756044","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["CR","BK4161"],"gpt_icon":0},{"id":"2566908998","title":"Crane NXT计划以1.2亿欧元收购Antares Vision公司30%的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2566908998","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566908998?lang=zh_cn&edition=full","pubTime":"2025-09-12 23:30","pubTimestamp":1757691007,"startTime":"0","endTime":"0","summary":"工业技术公司Crane NXT（CXT）早盘下跌2.8/%，该公司计划以1.2亿欧元收购安塔雷斯视觉公司（Antares Vision）30%的股份，并拟将该公司私有化。\n　　此次收购符合克瑞NXT扩大其在生命科学和食品饮料领域投资组合的战略。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-09-12/doc-infqhcie9208608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU0724618433.USD","LU1983299162.USD","LU0124384867.USD","LU0053671581.USD","NXT","LU0757428866.USD","BK4596","LU0823414551.USD","BK4096","CXT","LU1815336091.USD","LU2506951792.HKD","LU2298322129.HKD","LU0823414478.USD","BK4585","LU2294711713.HKD","CR","LU1978683503.SGD","BK4157","BK4588","LU2357125470.USD","BK4161","LU2249611893.SGD"],"gpt_icon":0},{"id":"2566135647","title":"强生(JNJ.US)获FDA批准突破性疗法 超80%患者肿瘤完全消失","url":"https://stock-news.laohu8.com/highlight/detail?id=2566135647","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566135647?lang=zh_cn&edition=full","pubTime":"2025-09-10 08:52","pubTimestamp":1757465557,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2592432038.USD","IE000M9KFDE8.USD","LU2505996509.AUD","BK4581","LU0345770308.USD","159992","LU1221951129.SGD","LU1732800096.USD","06978","LU1066053197.SGD","LU2112291526.USD","LU1280957306.USD","BK4568","LU1674673428.USD","LU0114720955.EUR","LU2471134952.CNY","CI","LU0795875086.SGD","IE00B3T34201.USD","LU1074936037.SGD","IE0034235303.USD","BCG","BK1574","LU0289739699.SGD","LU0432979614.USD","LU1032466523.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2133065610.SGD","BK4532","LU1894683348.USD","JNJ","LU2129689431.USD","IE00BJJMRZ35.SGD","LU0889566641.SGD","LU0203347892.USD","IE00B4R5TH58.HKD","CR","LU1778281490.HKD","IE00B3PB1722.GBP","BK4592","LU0098860793.USD","IE00B7SZLL34.SGD","LU1066051498.USD","BK4550","LU2089984988.USD","IE00BVYPNV92.GBP","LU1914381329.SGD","BK4135"],"gpt_icon":0},{"id":"2560359109","title":"人工智能公司SRE.AI宣布完成720万美元种子轮融资本轮融资由Salesforce Ventures和Crane Ve","url":"https://stock-news.laohu8.com/highlight/detail?id=2560359109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560359109?lang=zh_cn&edition=full","pubTime":"2025-08-20 21:11","pubTimestamp":1755695491,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4161","CR","161631"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cranenxt.com","stockEarnings":[{"period":"1week","weight":0.0256},{"period":"1month","weight":0.0153},{"period":"3month","weight":-0.0032},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1246},{"period":"ytd","weight":0.0324}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Crane NXT, Co.是一家一流的工业技术公司，提供专有和值得信赖的技术解决方案，以保护、检测和验证对客户最重要的东西。该公司是用于保护物理产品的先进专有微光学技术的先驱，其复杂的电子设备和相关软件利用了检测和传感技术的专有核心能力。","yearOnYearQuotes":[{"month":1,"riseRate":0.543478,"avgChangeRate":0.020828},{"month":2,"riseRate":0.717391,"avgChangeRate":0.035697},{"month":3,"riseRate":0.577778,"avgChangeRate":0.017327},{"month":4,"riseRate":0.608696,"avgChangeRate":0.002531},{"month":5,"riseRate":0.630435,"avgChangeRate":0.008709},{"month":6,"riseRate":0.586957,"avgChangeRate":0.005131},{"month":7,"riseRate":0.586957,"avgChangeRate":0.004401},{"month":8,"riseRate":0.347826,"avgChangeRate":-0.009516},{"month":9,"riseRate":0.369565,"avgChangeRate":-0.022666},{"month":10,"riseRate":0.586957,"avgChangeRate":0.009396},{"month":11,"riseRate":0.543478,"avgChangeRate":0.025826},{"month":12,"riseRate":0.608696,"avgChangeRate":0.018097}],"exchange":"NYSE","name":"crane","nameEN":"crane"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"crane(CR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供crane(CR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"crane,CR,crane股票,crane股票老虎,crane股票老虎国际,crane行情,crane股票行情,crane股价,crane股市,crane股票价格,crane股票交易,crane股票购买,crane股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"crane(CR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供crane(CR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}